Article Name Clinical & Diagnostic
Vial, a leading global contract research organization (CRO) providing next-generation clinical trial management services, announced the enrollment of the first patient in the pivotal clinical trial, "COOL-3s", evaluating the OcuCool system, developed by RecensMedical, Inc. ("RecensMedical"), a distinguished medical device company based in South Korea.
20th July, 2023
Surgeons in the Division of Thoracic Surgery at JFK University Medical Center first in the State of New Jersey to perform this surgery
19th July, 2023
Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter’s High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay Analyzers
18th July, 2023
Devyser's novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening and follow-up of stem cell transplanted patients fulfill IVDR requirements in Europe. These tests are the first post-transplant monitoring NGS products to be approved under the new, more comprehensive regulation that came into force in May 2022 and confirm Devyser's two NGS products meet the established safety, efficacy, and quality requirements.
18th July, 2023
Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments.
18th July, 2023
UK-based The Rodnight Partnership ties up with India's Pluss
18th July, 2023
Patient-Led Global Summit on Science, Policy, and Care Choice Drives Optimism
17th July, 2023
Affirms Strong Performance and Focus on India Amidst Ongoing Expansion
17th July, 2023
Brings Delhi’s first-ever comprehensive preventive health solution called Smart Gene Plan
17th July, 2023
Extending high-quality testing services to patients with latest & innovative diagnostic technologies
17th July, 2023
Aiming to reduce the number of advanced cancers in the country
17th July, 2023
OncoBindTM IDE Approved to Study Metastatic Cancer
14th July, 2023
hrough this partnership, Strive Health, Prominence Health Plan and Sierra Nevada Specialty Care will bring high-quality care to patients with kidney disease across Nevada
14th July, 2023
Genea Fertility is pleased to announce Melbourne Fertility Specialist Dr Catarina Ang is joining the world-leading fertility provider. Dr Ang, an experienced gynaecologist and obstetrician, will consult from Genea Fertility's new Melbourne City clinic, which is set to open its doors in September.
14th July, 2023
To enhance surgical skills of healthcare providers and widen patients’ access to innovative surgical procedures
13th July, 2023
Leading Global Skincare Brand Reinforces Commitment to Menopausal Skincare by Joining Forces with Innovative Wellness Technology to Empower Women During the Menopause Transition
13th July, 2023
eLovu Also Announces Integration with Brightside Health and Ruth Health
13th July, 2023
Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for radiotherapy. French medical technology company THERYQ, specializing in particle accelerators and radiotherapy systems, has provided Gustave Roussy's Department of Radiotherapy with the first FLASH clinical radiotherapy machine in France for treating superficial tumours.
13th July, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer